Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK

Bleomycin, a cytotoxic chemotherapy agent, forms a key component of curative regimens for lymphoma and germ cell tumours. It can be associated with severe toxicity, long-term complications and even death in extreme cases. There is a lack of evidence or consensus on how to prevent and monitor bleomyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Robert A., De La Peña, Hugo, Tsakok, Maria T., Joseph, Johnson, Stoneham, Sara, Shamash, Jonathan, Joffe, Johnathan, Mazhar, Danish, Traill, Zoe, Ho, Ling-Pei, Brand, Sue, Protheroe, Andrew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Consensus Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219480/
https://www.ncbi.nlm.nih.gov/pubmed/30356125
http://dx.doi.org/10.1038/s41416-018-0300-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219480/
https://www.ncbi.nlm.nih.gov/pubmed/30356125
http://dx.doi.org/10.1038/s41416-018-0300-x

Ejemplares similares